Starling Oncology (STLN) EBIT Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -27.36% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 35.45% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 44.08% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 12.63% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 22.64% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 16.30% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 8.67% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 30.20% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 11.91% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 32.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.39% |
| Mar 31, 2026 | 41.70% |
| Dec 31, 2025 | 34.94% |
| Sep 30, 2025 | 26.27% |
| Jun 30, 2025 | 15.08% |
| Mar 31, 2025 | 18.74% |
| Dec 31, 2024 | 33.65% |
| Sep 30, 2024 | -85.88% |
| Jun 30, 2024 | -144.76% |
| Mar 31, 2024 | -117.24% |
| Dec 31, 2023 | -25.60% |
| Sep 30, 2023 | -312.44% |
| Jun 30, 2023 | -325.02% |